×

Multi-lineage progenitor cells

  • US 7,622,108 B2
  • Filed: 08/22/2005
  • Issued: 11/24/2009
  • Est. Priority Date: 04/23/2004
  • Status: Active Grant
First Claim
Patent Images

1. A method of characterizing a population of multi-lineage progenitor cells (MLPC), said method comprising:

  • a) providing a purified population of MLPC, wherein said MLPC are positive for CD9, CD13, CD29, CD44, CD73, CD90 and CD105, and negative for CD10, CD34, CD41, CD45, Stro-1, Stage Specific Embryonic Antigen-3 (SSEA-3) and SSEA-4; and

    b) assessing expression in said population of MLPC of at least one mRNA selected from the group consisting of CXCR4, FLT3, CD133, ICAM2, ITGAX, TFRC, KIT, IL6R, IL7R, ITGAM, FLT3, PDGFRB, SELE, SELL, TFRC, ITGAL, ITGB2, PECAM1, ITGA2B, ITGA3, ITGA4, ITGA6, ICAM1, CD24, CD34, CD44, CD45, CD58, CD68, CD33, CD37, CD38, TERT and POU5F.

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×